Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving <scp>sodium‐glucose cotransporter‐2</scp> inhibitors versus other medications: A systematic review and meta‐analysis of observational cohort studies-Reference-Cited by-同舟云学术

Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium‐glucose cotransporter‐2 inhibitors versus other medications: A systematic review and meta‐analysis of observational cohort studies

Published:2024-04 Issue:6 Volume:26 Page:2487-2491
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Hodgson Anna¹,Gillies Clare L.²^ORCID,Highton Patrick³,Haddon Louise¹,Gharibzadeh Safoora²,Zaccardi Francesco²,Khunti Kamlesh²³

Affiliation:

1. Department of Health Sciences University of Leicester Leicester UK

2. Leicester Real World Evidence Unit, Leicester General Hospital University of Leicester Leicester UK

3. Leicester Diabetes Centre University of Leicester, Leicester General Hospital Leicester UK

Funder

National Institute for Health and Care Research

Publisher

Wiley

Reference12 articles.

1. Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus

2. Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis

3. Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

4. FDA Drug Safety Podcast: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana Invokamet Invokamet XR).https://www.fda.gov/drugs/fda‐drug‐safety‐podcasts/fda‐drug‐safety‐podcast‐fda‐confirms‐increased‐risk‐leg‐and‐foot‐amputations‐diabetes‐medicine

5. Sodium‐glucose co‐transporter‐2 inhibitors and major adverse limb events: A trial‐level meta‐analysis including 51 713 individuals

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta‐analysis of randomized controlled studies examining the effects of sodium‐glucose co‐transporter‐2 inhibitors on peripheral artery disease and risk of amputations;Diabetes, Obesity and Metabolism;2024-09-12

2. Key results from observational studies and real‐world evidence of sodium‐glucose cotransporter‐2 inhibitor effectiveness and safety in reducing cardio‐renal risk;Diabetes, Obesity and Metabolism;2024-06-10